Interleukin-27: A master regulator in inflammation

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2157-2160

  Fearon, Ursula ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 27; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; ONCOSTATIN M; OSTEOCLAST DIFFERENTIATION FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; INFLAMMATION; KERATINOCYTE; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVIUM; SYSTEMIC SCLEROSIS; TH1 CELL; TH17 CELL; TH2 CELL; VASCULAR ENDOTHELIUM;

ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; INTERLEUKIN-17;

EID: 79961102987     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30322     Document Type: Review

References (27)

1. Yoshida H, Nakaya M, Miyazaki Y,. Interleukin 27: a double-edged sword for offense and defense. J Leukoc Biol 2009; 86: 1295-303.
2. + T cells. Immunity 2002; 16: 779-90. (Pubitemid 34786477)
3. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004; 172: 2225-31. (Pubitemid 38182370)
4. Shahrara S, Huang Q, Mandelin AM II, Pope RM,. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R93.
5. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008; 67: 1474-9.
6. Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Muroi E, et al. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis 2011; 70: 194-200.
7. Schnurr M, Toy T, Shin A, Wagner M, Cebon J, Maraskovsky E,. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 2005; 105: 1582-9. (Pubitemid 40223678)
8. Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE, Tubbe I, Galle PR, et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-ÎB activation. J Immunol 2005; 174: 2814-24. (Pubitemid 40279698)
9. Guzzo C, Che Mat NF, Gee K,. Interleukin-27 induces a STAT1/3- and NF-ÎB-dependent proinflammatory cytokine profile in human monocytes. J Biol Chem 2010; 285: 24404-11.
10. Wong CK, Chen DP, Tam LS, Li EK, Yin YB, Lam CW,. Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12: R129.
11. + T cell generation with enhanced granzyme B expression by IL-27. J Immunol 2005; 175: 1686-93. (Pubitemid 41023072)
12. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003; 19: 645-55. (Pubitemid 37490790)
13. Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N,. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173: 1171-8. (Pubitemid 38924293)
14. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007; 179: 3268-75.
15. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7: 929-36. (Pubitemid 44263906)
16. + T cells partially through STAT3-dependent mechanism. J Immunol 2006; 177: 5377-85. (Pubitemid 44527610)
17. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007; 8: 1380-9. (Pubitemid 350131175)
18. Pickens SR, Chamberlain ND, Volin MV, Mandelin AM II, Agrawal H, Matsui M, et al. Local expression of interleukin-27 ameliorates collagen-induced arthritis. Arthritis Rheum 2011; 63: 2289-98.
19. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORÎ. Eur J Immunol 2008; 38: 1204-14.
20. Kalliolias GD, Gordon RA, Ivashkiv LB,. Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. J Immunol 2010; 185: 7047-56.
21. Furukawa M, Takaishi H, Takito J, Yoda M, Sakai S, Hikata T, et al. IL-27 abrogates receptor activator of NF-ÎB ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos. J Immunol 2009; 183: 2397-406.
22. Baker BJ, Park KW, Qin H, Ma X, Benveniste EN,. IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia. Glia 2010; 58: 1082-93.
23. Cocco C, Giuliani N, Di Carlo E, Ognio E, Storti P, Abeltino M, et al. Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clin Cancer Res 2010; 16: 4188-97.
24. Kennedy A, Ng CT, Biniecka M, Saber T, Taylor C, O'Sullivan J, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010; 62: 711-21.
25. Cao Y, Doodes PD, Glant TT, Finnegan A,. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008; 180: 922-30.
26. Villarino AV, Artis D, Bezbradica JS, Miller O, Saris CJ, Joyce S, et al. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. Int Immunol 2008; 20: 739-52. (Pubitemid 351791518)
27. Kryczek I, Wei S, Gong W, Shu X, Szeliga W, Vatan L, et al. Cutting edge: IFN-Î enables APC to promote memory Th17 and abate Th1 cell development. J Immunol 2008; 181: 5842-6.